| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Pathology [Q. P., J. M. N.] and Biophysics [Q. P., J. M., L-W. M.], Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway
By using a chemical extraction assay and confocal laser scanning fluorescence microscopy, the kinetic patterns of uptake, elimination, and localization of meso-tetra(hydroxyphenyl)porphine (m-THPP) and its corresponding chlorin (m-THPC) in tumors and various normal tissues of female C3D2/F1 mice bearing CaD2 mammary carcinoma were studied after an i.p. injection of either 5 mg/kg body weight of m-THPP or 1 mg/kg body weight of m-THPC. Moreover, the histological and ultrastructural alterations of the tumors were evaluated after photodynamic therapy (PDT) with m-THPP or m-THPC. The PDT efficacy with m-THPP and m-THPC was also compared. Both m-THPP and m-THPC had a similar kinetic pattern of distribution in the tumors and most normal tissues examined. The concentrations of the dyes in the tissues peaked at 2448 h after injection. The peak values of the uptake of m-THPP by the tissues were found to decrease in the following order: spleen > urinary tract > kidney > liver > lung > tumor > heart > skin > muscle > brain. However, higher concentrations of m-THPC were taken up by the tumors than by most of the normal tissues studied except for the liver, urinary tract, and skin. m-THPP was mainly localized in the stroma of the tumors, whereas m-THPC was distributed in both vascular interstitium and neoplastic cells of the tumors. Morphological studies showed that PDT with m-THPP resulted in destructive changes in the microvasculature of the tumors, whereas m-THPC-based PDT destroyed both vascular walls and tumor cells of the tumors. The m-THPP-PDT of the tumors was much less efficient than m-THPC-PDT of the tumors, although the dose of m-THPP used was five times higher than that of m-THPC. m-THPP and m-THPC have different efficiency of sensitizing tumors to photodestruction, although they are similar with respect to hydrophobicity. This is likely due to the differences in their intratumoral localization patterns and in their absorption spectra.
1 This work was supported by The Norwegian Cancer Society and The Association for International Cancer Research.
2 To whom requests for reprints should be addressed, at Department of Biophysics, Institute for Cancer Research, Montebello, 0310 Oslo, Norway.
Received 12/20/94. Accepted 4/17/95.
This article has been cited by other articles:
![]() |
D. A. Groneberg, A. Fischer, K. F. Chung, and H. Daniel Molecular Mechanisms of Pulmonary Peptidomimetic Drug and Peptide Transport Am. J. Respir. Cell Mol. Biol., March 1, 2004; 30(3): 251 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Groneberg, F. Doring, S. Theis, M. Nickolaus, A. Fischer, and H. Daniel Peptide transport in the mammary gland: expression and distribution of PEPT2 mRNA and protein Am J Physiol Endocrinol Metab, May 1, 2002; 282(5): E1172 - E1179. [Abstract] [Full Text] [PDF] |
||||
![]() |
D A Groneberg, P R Eynott, F Doring, Q Thai Dinh, T Oates, P J Barnes, K F Chung, H Daniel, and A Fischer Distribution and function of the peptide transporter PEPT2 in normal and cystic fibrosis human lung Thorax, January 1, 2002; 57(1): 55 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Peng, T. Warloe, J. Moan, A. Godal, F. Apricena, K.-E. Giercksky, and J. M. Nesland Antitumor Effect of 5-Aminolevulinic Acid-mediated Photodynamic Therapy Can Be Enhanced by the Use of a Low Dose of Photofrin in Human Tumor Xenografts Cancer Res., August 1, 2001; 61(15): 5824 - 5832. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. I. Fielding, G. A. Buonaccorsi, A. J. MacRobert, A. M. Hanby, M. R. Hetzel, and S. G. Bown Fine-Needle Interstitial Photodynamic Therapy of the Lung Parenchyma: Photosensitizer Distribution and Morphologic Effects of Treatment Chest, February 1, 1999; 115(2): 502 - 510. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |